Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 1,555 | 1,433 | 1,343 | 1,447 | 1,179 |
| Cost of Goods | 939 | 953 | 865 | 979 | 900 |
| Gross Profit | 616 | 480 | 478 | 468 | 279 |
| Operating Expenses | 1,667 | 1,607 | 1,630 | 1,767 | 1,806 |
| Operating Income | -112 | -174 | -287 | -320 | -627 |
| Interest Expense | 3 | 4 | 5 | 5 | 28 |
| Other Income | 0 | 0 | 0 | 2 | 6 |
| Pre-tax Income | -115 | -178 | -291 | -324 | -650 |
| Net Income Continuous | -115 | -178 | -291 | -324 | -650 |
| Net Income | $-115 | $-178 | $-291 | $-324 | $-650 |
| EPS Basic Total Ops | 0.00 | -0.03 | -0.03 | -0.03 | -0.09 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.03 | -0.03 | -0.07 |
| EPS Diluted Total Ops | 0.00 | -0.03 | -0.03 | -0.03 | -0.09 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.03 | -0.03 | -0.07 |
| EBITDA(a) | $-13 | $-77 | $-188 | $-221 | $-526 |